We have detected that you are using Internet Explorer to visit this website. Internet Explorer is now being phased out by Microsoft. As a result, NHS Digital no longer supports any version of Internet Explorer for our web-based products, as it involves considerable extra effort and expense, which cannot be justified from public funds. Some features on this site will not work. You should use a modern browser such as Edge, Chrome, Firefox, or Safari. If you have difficulty installing or accessing a different browser, contact your IT support team.
CQRS will be managed by the NHS Commissioning Support Units from 1 November 2020
CQRS will be managed by the NHS Commissioning Support Units from 1 November 2020. Learn more about the services CQRS will offer.
Purpose and outline
Evidence shows that early identification and treatment of diabetic eye disease could reduce sight loss. The main treatment for diabetic retinopathy is laser surgery.
The eligible population for diabetic eye screening are people with type 1 and type 2 diabetes aged 12 or over. Those already under the care of an ophthalmology specialist for the condition are not invited for screening. The programme offers pregnant women with type 1 or type 2 diabetes additional tests because of the risk of developing retinopathy.
For full details about this service, visit the government website.
Read the GP2DRS Data Provision Notice
How this service is commissioned and provided
This service is commissioned by Public Health England.
Important information about this service
Quality service start date: Please contact your RLO
Quality service end date: Please contact your RLO
Payment period: No payment
Collection frequency: Monthly
Manual or automatic: Automatic
Included in data collection: All system suppliers (TPP, INPS, Microtest and Emis)
Service type: Non quality service for direct patient care.
Payment count/clinical codes
No payment attached.
Why and how we process your data in the Diabetic Retinopathy Eye Screening system, and your rights.